ROS1 and lung adenocarcinoma: [86, 87] The ROS1 IHC has shown good concordance with FISH and reverse transcription polymerase chain reaction (RT-PCR) assays in lung adenocarcinoma and is used routinely in some pathology laboratories as a predictive biomarker for crizotinib.